posted on
Apr 13, 2021 09:31AM

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Message: Volume
New Message
Please
login
to post a reply